All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-δ

Journal of Leukocyte Biology

Volumn 90, Issue 2, 2011, Pages 235-247

  Uruno, Akira ^a   Noguchi, Naoya ^a   Matsuda, Ken ^a   Nata, Koji ^a   Yoshikawa, Takeo ^a   Chikamatsu, Youichiro ^a   Kagechika, Hiroyuki ^b   Harigae, Hideo ^a   Ito, Sadayoshi ^a   Okamoto, Hiroshi ^a   Sugawara, Akira ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adhesion; Endothelial cells; Retinoic acid receptor

Indexed keywords

CD38 ANTIGEN; CYCLOHEXIMIDE; HLA DR ANTIGEN; LE 540; MESSENGER RNA; PROTEIN KINASE C DELTA; PROTEIN KINASE C DELTA INHIBITOR; RECEPTOR BLOCKING AGENT; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR ANTAGONIST; RETINOIC ACID RECEPTOR BETA; ROTTLERIN; TAMIBAROTENE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; DNA FLANKING REGION; DNA STRUCTURE; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTRON; LEUKEMIA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINOIC ACID RESPONSE ELEMENT; RNA STABILITY; TRANSCRIPTION REGULATION;

ANTIGENS, CD38; BENZOATES; CELL ADHESION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HL-60 CELLS; HUMANS; LEUKEMIA; PROTEIN KINASE C-DELTA; RETINOIDS; TETRAHYDRONAPHTHALENES; TRETINOIN;

EID: 79961042781     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0109025     Document Type: Article

References (51)

1. Stevenson, G. T. (2006) CD38 as a therapeutic target. Mol. Med. 12, 345-346.
2. Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., Vaisitti, T., Aydin, S. (2008) Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev. 88, 841-886.
3. Jackson, D. G., Bell, J. I. (1990) Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J. Immunol. 144, 2811-2815.
4. Deaglio, S., Morra, M., Mallone, R., Ausiello, C. M., Prager, E., Garbarino, G., Dianzani, U., Stockinger, H., Malavasi, F. (1998) Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J. Immunol. 160, 395-402.
5. Drach, J., McQueen, T., Engel, H., Andreeff, M., Robertson, K. A., Collins, S. J., Malavasi, F., Mehta, K. (1994) Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-α. Cancer Res. 54, 1746-1752.
6. Gao, Y., Camacho, L. H., Mehta, K. (2007) Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-γ/interleukin-1β-dependent apoptosis of endothelial cells: implications in the etiology of retinoic acid syndrome. Leuk. Res. 31, 455-463.
7. Nata, K., Takamura, T., Karasawa, T., Kumagai, T., Hashioka, W., Tohgo, A., Yonekura, H., Takasawa, S., Nakamura, S., Okamoto, H. (1997) Human gene encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): organization, nucleotide sequence and alternative splicing. Gene 186, 285-292.
8. Kishimoto, H., Hoshino, S., Ohori, M., Kontani, K., Nishina, H., Suzawa, M., Kato, S., Katada, T. (1998) Molecular mechanism of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron. J. Biol. Chem. 273, 15429-15434.
9. Miwako, I., Kagechika, H. (2007) Tamibarotene. Drugs Today (Barc) 43, 563-568.
10. Takahashi, N., Breitman, T. R. (1994) Induction of differentiation and covalent binding to proteins by the synthetic retinoids Ch55 and Am80. Arch. Biochem. Biophys. 314, 82-89.
11. Uruno, A., Sugawara, A., Kudo, M., Sato, M., Sato, K., Ito, S., Takeuchi, K. (2003) Transcription suppression of thromboxane receptor gene expression by retinoids in vascular smooth muscle cells. Hypertens. Res. 26, 815-821.
12. Saito, A., Sugawara, A., Uruno, A., Kudo, M., Kagechika, H., Sato, Y., Owada, Y., Kondo, H., Sato, M., Kurabayashi, M., Imaizumi, M., Tsuchiya, S., Ito, S. (2007) All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. Endocrinology 148, 1412-1423.
13. Uruno, A., Sugawara, A., Kanatsuka, H., Arima, S., Taniyama, Y., Kudo, M., Takeuchi, K., Ito, S. (2004) Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells. Hypertens. Res. 27, 887-895.
14. Uruno, A., Sugawara, A., Kanatsuka, H., Kagechika, H., Saito, A., Sato, K., Kudo, M., Takeuchi, K., Ito, S. (2005) Upregulation of nitric oxide production in vascular endothelial cells by all-trans retinoic acid through the phosphoinositide 3-kinase/Akt pathway. Circulation 112, 727-736.
15. Uruno, A., Sugawara, A., Kudo, M., Satoh, F., Saito, A., Ito, S. (2008) Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase. Hypertens. Res. 31, 2085-2096.
16. Aggarwal, S., Kim, S. W., Cheon, K., Tabassam, F. H., Yoon, J. H., Koo, J. S. (2006) Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. Mol. Biol. Cell 17, 566-575.
17. Radominska-Pandya, A., Chen, G., Czernik, P. J., Little, J. M., Samokyszyn, V. M., Carter, C. A., Nowak, G. (2000) Direct interaction of all-transretinoic acid with protein kinase C (PKC). Implications for PKC signaling and cancer therapy. J. Biol. Chem. 275, 22324-22330.
18. Miano, J. M., Berk, B. C. (2000) Retinoids: versatile biological response modifiers of vascular smooth muscle phenotype. Circ. Res. 87, 355-362.
19. Dalton Jr., W. T., Ahearn, M. J., McCredie, K. B., Freireich, E. J., Stass, S. A., Trujillo, J. M. (1988) HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 71, 242-247.
20. Drach, J., Zhao, S., Malavasi, F., Mehta, K. (1993) Rapid induction of CD38 antigen on myeloid leukemia cells by all trans-retinoic acid. Biochem. Biophys. Res. Commun. 195, 545-550.
21. Frankel, S. R., Eardley, A., Lauwers, G., Weiss, M., Warrell Jr., R. P. (1992) The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann. Intern. Med. 117, 292-296.
22. Patatanian, E., Thompson, D. F. (2008) Retinoic acid syndrome: a review. J. Clin. Pharm. Ther. 33, 331-338.
23. Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Rowe, J. M., François, C., Larson, R. S., Wiernik, P. H. (2000) Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 95, 90-95.
24. Tobita, T., Takeshita, A., Kitamura, K., Ohnishi, K., Yanagi, M., Hiraoka, A., Karasuno, T., Takeuchi, M., Miyawaki, S., Ueda, R., Naoe, T., Ohno, R. (1997) Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by alltrans retinoic acid. Blood 90, 967-973.
25. Yung, W. K., Kyritsis, A. P., Gleason, M. J., Levin, V. A. (1996) Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid. Clin. Cancer Res. 2, 1931-1935.
26. Jaeckle, K. A., Hess, K. R., Yung, W. K., Greenberg, H., Fine, H., Schiff, D., Pollack, I. F., Kuhn, J., Fink, K., Mehta, M., Cloughesy, T., Nicholas, M. K., Chang, S., Prados, M., North American Brain Tumor Consortium (2003) Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. J. Clin. Oncol. 21, 2305-2311.
27. See, S. J., Levin, V. A., Yung, W. K., Hess, K. R., Groves, M. D. (2004) 13- cis-Retinoic acid in the treatment of recurrent glioblastoma multiforme. Neuro-oncol. 6, 253-258.
28. Lotan, R. (1996) Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers. Anticancer Res. 16, 2415-2419.
29. Pasquali, D., Rossi, V., Bellastella, G., Bellastella, A., Sinisi, A. A. (2006) Natural and synthetic retinoids in prostate cancer. Curr. Pharm. Des. 12, 1923-1929.
30. Páez-Pereda, M., Kovalovsky, D., Hopfner, U., Theodoropoulou, M., Pagotto, U., Uhl, E., Losa, M., Stalla, J., Grübler, Y., Missale, C., Arzt, E., Stalla, G. K. (2001) Retinoic acid prevents experimental Cushing syndrome. J. Clin. Invest. 108, 1123-1131.
31. Castillo, V., Giacomini, D., Páez-Pereda, M., Stalla, J., Labeur, M., Theodoropoulou, M., Holsboer, F., Grossman, A. B., Stalla, G. K., Arzt, E. (2006) Retinoic acid as a novel medical therapy for Cushing's disease in dogs. Endocrinology 147, 4438-4444.
32. Gavrielides, M. V., Gonzalez-Guerrico, A. M., Riobo, N. A., Kazanietz, M. G. (2006) Androgens regulate protein kinase Cδ transcription and modulate its apoptotic function in prostate cancer cells. Cancer Res. 66, 11792-11801.
33. Berry, D. M., Antochi, R., Bhatia, M., Meckling-Gill, K. A. (1996) 1,25- Dihydroxyvitamin D3 stimulates expression and translocation of protein kinase Cα and Cβ via a nongenomic mechanism and rapidly induces phosphorylation of a 33-kDa protein in acute promyelocytic NB4 cells. J. Biol. Chem. 271, 16090-16096.
34. Suh, K. S., Tatunchak, T. T., Crutchley, J. M., Edwards, L. E., Marin, K. G., Yuspa, S. H. (2003) Genomic structure and promoter analysis of PKC-β. Genomics 82, 57-67.
35. Navakauskiene, R., Kulyte, A., Treigyte, G., Gineitis, A., Magnusson, K. E. (2003) Translocation of transcription regulators into the nucleus during granulocyte commitment of HL-60 cells. Biochem. Cell Biol. 81, 285-295.
36. Kambhampati, S., Li, Y., Verma, A., Sassano, A., Majchrzak, B., Deb, D. K., Parmar, S., Giafis, N., Kalvakolanu, D. V., Rahman, A., Uddin, S., Minucci, S., Tallman, M. S., Fish, E. N., Platanias, L. C. (2003) Activation of protein kinase C β by all-trans-retinoic acid. J. Biol. Chem. 278, 32544-32551.
37. Zhao, K. W., Li, X., Zhao, Q., Huang, Y., Li, D., Peng, Z. G., Shen, W. Z., Zhao, J., Zhou, Q., Chen, Z., Sims, P. J., Wiedmer, T., Chen, G. Q. (2004) Protein kinase Cβ mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation. Blood 104, 3731-3738.
38. Koya, D., King, G. L. (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859-866.
39. Babazono, T., Kapor-Drezgic, J., Dlugosz, J. A., Whiteside, C. (1998) Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 47, 668-676.
40. Kapor-Drezgic, J., Zhou, X., Babazono, T., Dlugosz, J. A., Hohman, T., Whiteside, C. (1999) Effect of high glucose on mesangial cell protein kinase C-δ and -ε is polyol pathway-dependent. J. Am. Soc. Nephrol. 10, 1193-1203.
41. Duprez, E., Wagner, K., Koch, H., Tenen, D. G. (2003) C/EBPβ: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. EMBO J. 22, 5806-5816.
42. Zhao, K. W., Li, D., Zhao, Q., Huang, Y., Silverman, R. H., Sims, P. J., Chen, G. Q. (2005) Interferon-α-induced expression of phospholipid scramblase 1 through STAT1 requires the sequential activation of protein kinase Cδ and JNK. J. Biol. Chem. 280, 42707-42714.
43. Zhang, H., Forman, H. J. (2008) Acrolein induces heme oxygenase-1 through PKC-δ and PI3K in human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 38, 483-490.
44. Fan, C. Y., Katsuyama, M., Yabe-Nishimura, C. (2005) PKCδ mediates upregulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCδ in vascular hypertrophy. Biochem. J. 390, 761-767.
45. Page, K., Li, J., Corbit, K. C., Rumilla, K. M., Soh, J. W., Weinstein, I. B., Albanese, C., Pestell, R. G., Rosner, M. R., Hershenson, M. B. (2002) Regulation of airway smooth muscle cyclin D1 transcription by protein kinase C-δ. Am. J. Respir. Cell Mol. Biol. 27, 204-213.
46. Jin, D., Liu, H. X., Hirai, H., Torashima, T., Nagai, T., Lopatina, O., Shnayder, N. A., Yamada, K., Noda, M., Seike, T., et al. (2007) CD38 is critical for social behavior by regulating oxytocin secretion. Nature 446, 41-45.
47. Lerer, E., Levi, S., Israel, S., Yaari, M., Nemanov, L., Mankuta, D., Nurit, Y., Ebstein, R. P. (2010) Low CD38 expression in lymphoblastoid cells and haplotypes are both associated with autism in a family-based study. Autism Res. 3, 293-302.
48. Munesue, T., Yokoyama, S., Nakamura, K., Anitha, A., Yamada, K., Hayashi, K., Asaka, T., Liu, H. X., Jin, D., Koizumi, K., et al. (2010) Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci. Res. 67, 181-191.
49. Aydin, S., Rossi, D., Bergui, L., D'Arena, G., Ferrero, E., Bonello, L., Omedé, P., Novero, D., Morabito, F., Carbone, A., Gaidano, G., Malavasi, F., Deaglio, S. (2008) CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? Blood 111, 5646-5653.
50. González-Escribano, M. F., Aguilar, F., Torres, B., Sánchez-Román, J., Núñez-Roldán, A. (2004) CD38 polymorphisms in Spanish patients with systemic lupus erythematosus. Hum. Immunol. 65, 660-664.
51. Drummond, F. J., Mackrill, J. J., O'sullivan, K., Daly, M., Shanahan, F., Molloy, M. G. (2006) CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss. J. Bone Miner. Metab. 24, 28-35.